Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter double-blind randomized Phase 3 trial of S-555739 in perennial allergic rhinitis
jRCT2080222175Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of asapiprant in perennial rhinitis, sponsored by Shionogi & Co., Ltd.
02
Drugs
asapiprant
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on jRCT2080222175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222175.